Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PMOS: Kaletra Double Protease Inhibitors

NCT01075191 is registered in ClinicalTrials.gov with AbbVie (prior sponsor, Abbott) as lead sponsor.

NCT NCT01075191
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01075191 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PMOS: Kaletra Double Protease Inhibitors
Lead sponsor
AbbVie (prior sponsor, Abbott)
Phase
Observational
Overall status
Completed
Start date
January 31, 2004
Completion date
September 30, 2011
Enrollment
65 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

human immunodeficiency virus